Ryogo Shimizu   Kazuhisa Murai   Kensuke Tanaka   Yuga Sato   Naho Takeda   Saki Nakasyo   Takayoshi Shirasaki   Kazunori Kawaguchi   Tetsuro Shimakami   Kouki Nio   Yuki Nakaya   Harumi Kagiwada   Katsuhisa Horimoto   Masashi Mizokami   Shuichi Kaneko   Kazumoto Murata   Taro Yamashita   Masao Honda   
Hepatology Communications 8(1) e0351 2024年1月 [査読有り]
Background:
Recent clinical studies have suggested that the risk of developing HCC might be lower in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate than in patients receiving entecavir, although there is no difference ...